# FARALLON CAPITAL MANAGEMENT, L.L.C.

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 909661. Source: https://holderbook.com/funds/909661-farallon-capital-management-l-l-c/

- Reported value: $21.7B
- Positions: 89
- Weight of the ten largest: 62.1%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $4.5B | 0 | 20.7% | 1 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $2.5B | 13,550,796 | 11.7% | 22 |
| ELECTRONIC ARTS INC | [EA](https://holderbook.com/stocks/EA/) | $1.6B | 7,919,500 | 7.5% | 3 |
| BRIDGEBIO PHARMA INC | [BBIO](https://holderbook.com/stocks/BBIO/) | $800.1M | 10,743,063 | 3.7% | 8 |
| PROTAGONIST THERAPEUTICS INC | [PTGX](https://holderbook.com/stocks/PTGX/) | $778.2M | 6,348,906 | 3.6% | 31 |
| EXELIXIS INC | [EXEL](https://holderbook.com/stocks/EXEL/) | $732.8M | 13,468,010 | 3.4% | 31 |
| LIQUIDIA CORPORATION | [LQDA](https://holderbook.com/stocks/LQDA/) | $666.9M | 8,365,038 | 3.1% | 10 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $627.5M | 2,632,994 | 2.9% | 5 |
| LANTHEUS HLDGS INC | [LNTH](https://holderbook.com/stocks/LNTH/) | $619.4M | 5,583,479 | 2.9% | 14 |
| NATERA INC | [NTRA](https://holderbook.com/stocks/NTRA/) | $602.2M | 2,218,366 | 2.8% | 21 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $528.1M | 1,270,532 | 2.4% | 14 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $526.0M | 1,049,185 | 2.4% | 27 |
| ROIVANT SCIENCES LTD | [ROIV](https://holderbook.com/stocks/ROIV/) | $506.4M | 14,309,000 | 2.3% | 13 |
| AON PLC | [AON](https://holderbook.com/stocks/AON/) | $458.6M | 1,382,562 | 2.1% | 10 |
| BOSTON SCIENTIFIC CORP | [BSX](https://holderbook.com/stocks/BSX/) | $449.0M | 10,521,184 | 2.1% | 24 |
| BROADCOM INC | [AVGO](https://holderbook.com/stocks/AVGO/) | $435.1M | 1,151,800 | 2.0% | 3 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $415.1M | 1,112,863 | 1.9% | 31 |
| TANGO THERAPEUTICS INC | [TNGX](https://holderbook.com/stocks/TNGX/) | $383.8M | 12,277,000 | 1.8% | 7 |
| KKR & CO INC | [KKR](https://holderbook.com/stocks/KKR/) | $378.0M | 4,118,300 | 1.7% | 3 |
| SYNOPSYS INC | [SNPS](https://holderbook.com/stocks/SNPS/) | $370.1M | 829,600 | 1.7% | 3 |
| BEAM THERAPEUTICS INC | [BEAM](https://holderbook.com/stocks/BEAM/) | $351.3M | 10,236,396 | 1.6% | 22 |
| CRINETICS PHARMACEUTICALS IN | [CRNX](https://holderbook.com/stocks/CRNX/) | $336.4M | 8,989,098 | 1.6% | 12 |
| GRAIL INC | [GRAL](https://holderbook.com/stocks/GRAL/) | $284.1M | 4,161,584 | 1.3% | 5 |
| WABTEC | [WAB](https://holderbook.com/stocks/WAB/) | $241.2M | 894,503 | 1.1% | 31 |
| IMMUNOVANT INC | [IMVT](https://holderbook.com/stocks/IMVT/) | $223.7M | 5,805,000 | 1.0% | 9 |
| TWIST BIOSCIENCE CORP | [TWST](https://holderbook.com/stocks/TWST/) | $219.8M | 2,136,400 | 1.0% | 9 |
| AGIOS PHARMACEUTICALS INC | [AGIO](https://holderbook.com/stocks/AGIO/) | $219.6M | 5,917,400 | 1.0% | 27 |
| ARAMARK | [ARMK](https://holderbook.com/stocks/ARMK/) | $206.3M | 3,625,731 | 1.0% | 23 |
| BAIDU INC | [BIDU](https://holderbook.com/stocks/BIDU/) | $137.6M | 1,203,785 | 0.6% | 4 |
| NOVO-NORDISK A S | [NVO](https://holderbook.com/stocks/NVO/) | $125.6M | 2,619,000 | 0.6% | 2 |
| ACADIA HEALTHCARE COMPANY IN | [ACHC](https://holderbook.com/stocks/ACHC/) | $124.6M | 4,220,800 | 0.6% | 2 |
| BRIGHTSPRING HEALTH SVCS INC | [BTSG](https://holderbook.com/stocks/BTSG/) | $120.8M | 1,732,800 | 0.6% | 10 |
| ASTRAZENECA PLC | [AZN](https://holderbook.com/stocks/AZN/) | $108.8M | 574,000 | 0.5% | 2 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $103.6M | 408,000 | 0.5% | 2 |
| ISHARES TR | [SOXX](https://holderbook.com/stocks/SOXX/) | $83.3M | 0 | 0.4% | 1 |
| STRATEGY INC | - | $75.4M | 87,858,000 | 0.3% | 2 |
| PARABILIS MEDICINES INC | [PBLS](https://holderbook.com/stocks/PBLS/) | $64.8M | 2,368,200 | 0.3% | 1 |
| NOVARTIS AG | [NVS](https://holderbook.com/stocks/NVS/) | $56.9M | 363,000 | 0.3% | 1 |
| GUARDANT HEALTH INC | [GH](https://holderbook.com/stocks/GH/) | $48.3M | 322,200 | 0.2% | 5 |
| VNET GROUP INC | - | $46.8M | 45,000,000 | 0.2% | 2 |
| AVALO THERAPEUTICS INC | [AVTX](https://holderbook.com/stocks/AVTX/) | $46.2M | 2,498,000 | 0.2% | 2 |
| JOYY INC | [JOYY](https://holderbook.com/stocks/JOYY/) | $46.1M | 699,200 | 0.2% | 6 |
| ASSEMBLY BIOSCIENCES INC | [ASMB](https://holderbook.com/stocks/ASMB/) | $44.1M | 1,604,590 | 0.2% | 4 |
| ENANTA PHARMACEUTICALS INC | [ENTA](https://holderbook.com/stocks/ENTA/) | $35.3M | 2,418,202 | 0.2% | 31 |
| MAZE THERAPEUTICS INC | [MAZE](https://holderbook.com/stocks/MAZE/) | $33.1M | 1,107,814 | 0.2% | 2 |
| CG ONCOLOGY INC | [CGON](https://holderbook.com/stocks/CGON/) | $28.4M | 0 | 0.1% | 5 |
| MERCK & CO INC | [MRK](https://holderbook.com/stocks/MRK/) | $25.6M | 199,000 | 0.1% | 2 |
| WARBY PARKER INC | [WRBY](https://holderbook.com/stocks/WRBY/) | $25.1M | 828,000 | 0.1% | 1 |
| PERCEPTIVE CAP SOLUTIONS COR | [PCSC](https://holderbook.com/stocks/PCSC/) | $24.5M | 2,250,000 | 0.1% | 3 |
| KAILERA THERAPEUTICS INC | [KLRA](https://holderbook.com/stocks/KLRA/) | $24.2M | 1,100,000 | 0.1% | 1 |
| RIO TINTO PLC | [RIO](https://holderbook.com/stocks/RIO/) | $17.4M | 183,475 | 0.1% | 2 |
| AXALTA COATING SYS LTD | [AXTA](https://holderbook.com/stocks/AXTA/) | $16.4M | 478,000 | 0.1% | 1 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $16.3M | 122,000 | 0.1% | 4 |
| VNET GROUP INC | [VNET](https://holderbook.com/stocks/VNET/) | $16.0M | 1,992,000 | 0.1% | 16 |
| NETEASE COM INC | [NTES](https://holderbook.com/stocks/NTES/) | $15.8M | 123,500 | 0.1% | 2 |
| BIOGEN INC | [BIIB](https://holderbook.com/stocks/BIIB/) | $15.3M | 71,000 | 0.1% | 1 |
| TAYSHA GENE THERAPIES INC | [TSHA](https://holderbook.com/stocks/TSHA/) | $15.3M | 2,250,000 | 0.1% | 1 |
| MOBIA MED INC | - | $15.1M | 1,128,557 | 0.1% | 1 |
| STRATEGY INC | - | $14.2M | 15,000,000 | 0.1% | 1 |
| MINERVA NEUROSCIENCES INC | [NERV](https://holderbook.com/stocks/NERV/) | $13.1M | 2,365,000 | 0.1% | 3 |
| ALAMAR BIOSCIENCES INC | [ALMR](https://holderbook.com/stocks/ALMR/) | $12.5M | 462,900 | 0.1% | 1 |
| ALVOTECH | [ALVO](https://holderbook.com/stocks/ALVO/) | $10.6M | 2,859,675 | 0.0% | 8 |
| BETA BIONICS INC | [BBNX](https://holderbook.com/stocks/BBNX/) | $9.3M | 595,000 | 0.0% | 6 |
| INFLARX NV | [IFRX](https://holderbook.com/stocks/IFRX/) | $7.4M | 3,325,000 | 0.0% | 1 |
| SCOTTS MIRACLE-GRO CO | [SMG](https://holderbook.com/stocks/SMG/) | $6.0M | 88,000 | 0.0% | 1 |
| WAYSTAR HLDG CORP | [WAY](https://holderbook.com/stocks/WAY/) | $5.4M | 264,900 | 0.0% | 1 |
| BRUNSWICK CORP | [BC](https://holderbook.com/stocks/BC/) | $5.1M | 61,000 | 0.0% | 1 |
| GENTEX CORP | [GNTX](https://holderbook.com/stocks/GNTX/) | $5.0M | 199,000 | 0.0% | 1 |
| IDEXX LABS INC | [IDXX](https://holderbook.com/stocks/IDXX/) | $4.7M | 9,000 | 0.0% | 1 |
| PRIME MEDICINE INC | [PRME](https://holderbook.com/stocks/PRME/) | $4.6M | 1,240,843 | 0.0% | 10 |
| COMMERCIAL METALS CO | [CMC](https://holderbook.com/stocks/CMC/) | $4.2M | 67,000 | 0.0% | 1 |
| JATT II ACQUISITION CORP | - | $3.4M | 300,000 | 0.0% | 1 |
| SAGIMET BIOSCIENCES INC | [SGMT](https://holderbook.com/stocks/SGMT/) | $3.2M | 415,000 | 0.0% | 1 |
| STRATEGY INC | - | $2.3M | 2,632,000 | 0.0% | 1 |
| SUMMIT MIDSTREAM CORPORATION | [SMC](https://holderbook.com/stocks/SMC/) | $1.7M | 58,214 | 0.0% | 8 |
| TEVA PHARMACEUTICAL INDS LTD | [TEVA](https://holderbook.com/stocks/TEVA/) | $1.4M | 40,000 | 0.0% | 4 |
| REVOLUTION MEDICINES INC | [RVMDW](https://holderbook.com/stocks/RVMDW/) | $1.1M | 120,085 | 0.0% | 11 |
| COGENT BIOSCIENCES INC | [COGT](https://holderbook.com/stocks/COGT/) | $657.9K | 17,000 | 0.0% | 23 |
| ALEANNA INC | [ANNAW](https://holderbook.com/stocks/ANNAW/) | $297.0K | 990,000 | 0.0% | 7 |
| ALEANNA INC | [ANNA](https://holderbook.com/stocks/ANNA/) | $227.4K | 78,400 | 0.0% | 7 |
| WELLTOWER INC | [WELL](https://holderbook.com/stocks/WELL/) | $227.0K | 1,000 | 0.0% | 3 |
| SOLID POWER INC | [SLDPW](https://holderbook.com/stocks/SLDPW/) | $41.4K | 405,316 | 0.0% | 19 |
| BLUE GOLD LTD | [BGLWW](https://holderbook.com/stocks/BGLWW/) | $30.7K | 255,800 | 0.0% | 4 |
| PACIFIC BIOSCIENCES CALIF IN | [PACB](https://holderbook.com/stocks/PACB/) | $23.9K | 14,200 | 0.0% | 15 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $18.4K | 14,400 | 0.0% | 10 |
| NVNI GROUP LIMITED | [NVNIW](https://holderbook.com/stocks/NVNIW/) | $17.6K | 375,000 | 0.0% | 11 |
| CANOPY GROWTH CORPORATION | [CGC](https://holderbook.com/stocks/CGC/) | $17.1K | 18,000 | 0.0% | 9 |
| RANI THERAPEUTICS HLDGS INC | [RANI](https://holderbook.com/stocks/RANI/) | $15.7K | 20,700 | 0.0% | 3 |
| BEYOND MEAT INC | [BYND](https://holderbook.com/stocks/BYND/) | $14.2K | 19,000 | 0.0% | 5 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +21.5% | +14.8% | +6.7% | 98% |
| Q1 2026 | -5.4% | -4.6% | -0.8% | 95% |
| Q4 2025 | +8.0% | +2.4% | +5.6% | 100% |
| Q3 2025 | +4.5% | +7.8% | -3.3% | 98% |
| Q2 2025 | +5.7% | +10.5% | -4.7% | 101% |
| Q1 2025 | -2.6% | -4.6% | +1.9% | 87% |
| Q4 2024 | +0.8% | +2.1% | -1.3% | 96% |
| Q3 2024 | +9.7% | +5.4% | +4.2% | 97% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $21.7B | 89 |
| Q1 2026 | $19.1B | 173 |
| Q4 2025 | $23.1B | 153 |
| Q3 2025 | $24.4B | 144 |
| Q2 2025 | $23.8B | 145 |
| Q1 2025 | $20.9B | 146 |
| Q4 2024 | $22.8B | 150 |
| Q3 2024 | $22.8B | 165 |
| Q2 2024 | $23.3B | 166 |
| Q1 2024 | $23.6B | 175 |
| Q4 2023 | $21.9B | 158 |
| Q3 2023 | $21.4B | 164 |